20100811
 Russell 2000 Tumbles 4%, Moving Into Red on Year   By Peterson, Kristina, The Wall Street Journal,  Aug 12, 2010  Myriad Genetics, which makes molecular diagnostic tests, fell 60 cents, or 3.8%, to 14.99, after its fiscal fourth-quarter earnings rose 45% on a tax gain and prior-year impacts from discontinued operations, but the Salt Lake City company was pessimistic about its new fiscal year, forecasting earnings that were below the analysts' expectations.   
